James J Maciejko, PhD
St. John Hospital Lipid Clinic
Hospital Privileges: St. John Hospital and Medical Center
Specialty(s): Cardiology/Cardiovascular Disease
Fellowship: Harvard Medical School, Mayo Clinic Foundation
James Maciejko has long been recognized as an expert in lipoprotein metabolism and the prevention of atherosclerotic cardiovascular disease. In 1983, he and colleagues at the Mayo Clinic were among the first to describe the inverse relationship between plasma apolipoprotein (APO) A-1 and coronary artery disease. That same year, he received appointments to the staffs of Pfizer Central Research and the Yale University School of Medicine faculty. Shorly thereafter, he became director of the Center of Lipid Metabolism and Atherosclerosis at Sinai Hospital in Detroit, as well as Associate Professor of Internal Medicine at Wayne State University. In 2000, he became director of the Preventive Cardiology Program at St. John Hospital and Medical Center and director of the St. John Health Lipid Laboratory, which is certified by the National Heart, Lung and Blood Institute and other leading certification bodies. Mr. Maciejko has published more than 70 original papers in leading medical journals and is the author of two books. He is a fellow of the American College of Cardiology and the Council of Arteriosclerosis, Thrombosis and Vascular Biology of the American Heart Association. He is a member of the National Lipid Association and the American Heart Association's Council on Nutrition, Physicial Activity and Metabolism. He served as Chairman of the Lipoprotein and Vascular Disease Division of the American Association of Clinical Chemistry in 2001. In 2004, he was recognized as a "Top Doc" by Hour Detroit magazine for his work with lipid patients and diseases.